Docusign (NASDAQ:DOCU) Director Sells $18,264.60 in Stock

Docusign Inc. (NASDAQ:DOCUGet Free Report) Director Teresa Briggs sold 365 shares of Docusign stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $50.04, for a total value of $18,264.60. Following the completion of the transaction, the director directly owned 10,263 shares in the company, valued at $513,560.52. This trade represents a 3.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Price Performance

Shares of Docusign stock opened at $50.94 on Friday. The business’s 50 day simple moving average is $47.74 and its two-hundred day simple moving average is $54.21. The stock has a market capitalization of $9.90 billion, a P/E ratio of 34.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.92. Docusign Inc. has a one year low of $40.16 and a one year high of $94.67.

Docusign (NASDAQ:DOCUGet Free Report) last announced its quarterly earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $830.24 million for the quarter, compared to analysts’ expectations of $824.71 million. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.90 EPS. Sell-side analysts expect that Docusign Inc. will post 1.76 earnings per share for the current fiscal year.

Docusign declared that its Board of Directors has approved a share buyback program on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 21% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

DOCU has been the topic of a number of analyst reports. BTIG Research reaffirmed a “buy” rating and issued a $70.00 price target on shares of Docusign in a research note on Wednesday, March 18th. Citizens Jmp decreased their price target on Docusign from $124.00 to $86.00 and set a “market outperform” rating on the stock in a research note on Wednesday, March 18th. Bank of America initiated coverage on Docusign in a research note on Tuesday, March 31st. They issued an “underperform” rating and a $52.00 price target on the stock. Robert W. Baird decreased their price target on Docusign from $75.00 to $55.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Finally, Royal Bank Of Canada cut their price objective on Docusign from $70.00 to $55.00 and set a “sector perform” rating on the stock in a research report on Wednesday, March 18th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $61.40.

View Our Latest Research Report on Docusign

Institutional Investors Weigh In On Docusign

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DOCU. Central Pacific Bank Trust Division purchased a new stake in Docusign in the fourth quarter worth $25,000. Modus Advisors LLC purchased a new stake in Docusign in the fourth quarter worth $27,000. Torren Management LLC purchased a new stake in Docusign in the fourth quarter worth $28,000. Aventura Private Wealth LLC purchased a new stake in Docusign in the fourth quarter worth $30,000. Finally, True Wealth Design LLC grew its stake in Docusign by 105.2% in the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares during the period. 77.64% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

Docusign Company Profile

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Featured Articles

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.